Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1999;7(3):158–164. doi: 10.1002/(SICI)1098-0997(1999)7:3<158::AID-IDOG8>3.0.CO;2-V

A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy.

L O Eckert 1, D H Watts 1, L A Koutsky 1, S E Hawes 1, C E Stevens 1, J Kuypers 1, N B Kiviat 1
PMCID: PMC1784734  PMID: 10371475

Abstract

OBJECTIVE: To compare the prevalence and type of human papillomavirus (HPV) infections in the genital tract of human-immunodeficiency-virus- (HIV) seropositive and -seronegative women matched for cytology and to examine prospectively the relationship of HPV DNA, colposcopic findings and cervical squamous intraepithelial lesions (SIL) in these matched seropositive and seronegative cohorts. METHODS: A matched prospective study of HIV-seropositive and -seronegative women undergoing cytologic screening, colposcopy, and testing for HPV DNA and other infections at each visit. RESULTS: Twenty-three HIV-seropositive women were matched with 23 seronegative women by cervical cytology reading, lifetime number of sexual partners, age, and follow-up length. Fourteen pairs of these women had follow-up visits every 4 months, for 56 and 53 total visits in seropositive and seronegative women, respectively. After matching, the groups had a similar overall prevalence of HPV DNA and of HPV oncogenic (high risk) types at baseline. On follow up, HIV-seropositive women were more likely than seronegative women to develop SIL (38% vs. 10%), less likely to have negative cytology (34% vs. 60%, overall P = 0.03), more visits with HPV DNA detected (68% vs. 40% P = 0.04), and more visits with multiple HPV DNA types detected (18% vs. 0%, P = 0.02). Colposcopic lesions in the seropositive women were more likely to have sharp borders or mosaicism or to be thick white (P = 0.009). CONCLUSIONS: After matching for baseline Papanicolaou smear readings, these data suggest that over time seropositive women have more visits that yield abnormal cytology, more persistent HPV DNA detection, and more colposcopic abnormalities than seronegative women.

Full Text

The Full Text of this article is available as a PDF (590.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Critchlow C. W., Surawicz C. M., Holmes K. K., Kuypers J., Daling J. R., Hawes S. E., Goldbaum G. M., Sayer J., Hurt C., Dunphy C. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 1995 Nov;9(11):1255–1262. doi: 10.1097/00002030-199511000-00007. [DOI] [PubMed] [Google Scholar]
  2. Daling J. R., Sherman K. J., Weiss N. S. Risk factors for condyloma acuminatum in women. Sex Transm Dis. 1986 Jan-Mar;13(1):16–18. doi: 10.1097/00007435-198601000-00004. [DOI] [PubMed] [Google Scholar]
  3. Eckert L. O., Koutsky L. A., Kiviat N. B., Krone M. R., Stevens C. E., Eschenbach D. A. The inflammatory Papanicolaou smear: what does it mean? Obstet Gynecol. 1995 Sep;86(3):360–366. doi: 10.1016/0029-7844(95)00196-X. [DOI] [PubMed] [Google Scholar]
  4. Feingold A. R., Vermund S. H., Burk R. D., Kelley K. F., Schrager L. K., Schreiber K., Munk G., Friedland G. H., Klein R. S. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1990;3(9):896–903. [PubMed] [Google Scholar]
  5. Fruchter R. G., Maiman M., Sedlis A., Bartley L., Camilien L., Arrastia C. D. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996 Mar;87(3):338–344. doi: 10.1016/0029-7844(95)00408-4. [DOI] [PubMed] [Google Scholar]
  6. Gisslén M., Chiodi F., Fuchs D., Norkrans G., Svennerholm B., Wachter H., Hagberg L. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis. 1994;26(5):523–533. doi: 10.3109/00365549409011810. [DOI] [PubMed] [Google Scholar]
  7. Kiviat N. B., Koutsky L. A., Paavonen J. A., Galloway D. A., Critchlow C. W., Beckmann A. M., McDougall J. K., Peterson M. L., Stevens C. E., Lipinski C. M. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis. 1989 Feb;159(2):293–302. doi: 10.1093/infdis/159.2.293. [DOI] [PubMed] [Google Scholar]
  8. Klein R. S., Ho G. Y., Vermund S. H., Fleming I., Burk R. D. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis. 1994 Dec;170(6):1404–1409. doi: 10.1093/infdis/170.6.1404. [DOI] [PubMed] [Google Scholar]
  9. Koutsky L. A., Holmes K. K., Critchlow C. W., Stevens C. E., Paavonen J., Beckmann A. M., DeRouen T. A., Galloway D. A., Vernon D., Kiviat N. B. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992 Oct 29;327(18):1272–1278. doi: 10.1056/NEJM199210293271804. [DOI] [PubMed] [Google Scholar]
  10. Lafeuillade A., Tamalet C., Pellegrino P., de Micco P., Vignoli C., Quilichini R. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr. 1994 Oct;7(10):1028–1033. [PubMed] [Google Scholar]
  11. Laga M., Icenogle J. P., Marsella R., Manoka A. T., Nzila N., Ryder R. W., Vermund S. H., Heyward W. L., Nelson A., Reeves W. C. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Int J Cancer. 1992 Jan 2;50(1):45–48. doi: 10.1002/ijc.2910500110. [DOI] [PubMed] [Google Scholar]
  12. Ley C., Bauer H. M., Reingold A., Schiffman M. H., Chambers J. C., Tashiro C. J., Manos M. M. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst. 1991 Jul 17;83(14):997–1003. doi: 10.1093/jnci/83.14.997. [DOI] [PubMed] [Google Scholar]
  13. Maiman M., Fruchter R. G., Serur E., Remy J. C., Feuer G., Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol. 1990 Sep;38(3):377–382. doi: 10.1016/0090-8258(90)90077-x. [DOI] [PubMed] [Google Scholar]
  14. Martinez J., Smith R., Farmer M., Resau J., Alger L., Daniel R., Gupta J., Shah K., Naghashfar Z. High prevalence of genital tract papillomavirus infection in female adolescents. Pediatrics. 1988 Oct;82(4):604–608. [PubMed] [Google Scholar]
  15. Rosenfeld W. D., Vermund S. H., Wentz S. J., Burk R. D. High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescents. Am J Dis Child. 1989 Dec;143(12):1443–1447. doi: 10.1001/archpedi.1989.02150240065018. [DOI] [PubMed] [Google Scholar]
  16. Schrager L. K., Friedland G. H., Maude D., Schreiber K., Adachi A., Pizzuti D. J., Koss L. G., Klein R. S. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1989;2(6):570–575. [PubMed] [Google Scholar]
  17. Schäfer A., Friedmann W., Mielke M., Schwartländer B., Koch M. A. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol. 1991 Feb;164(2):593–599. doi: 10.1016/s0002-9378(11)80029-3. [DOI] [PubMed] [Google Scholar]
  18. Seck A. C., Faye M. A., Critchlow C. W., Mbaye A. D., Kuypers J., Woto-Gaye G., Langley C., De E. B., Holmes K. K., Kiviat N. B. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. Int J STD AIDS. 1994 May-Jun;5(3):189–193. doi: 10.1177/095646249400500307. [DOI] [PubMed] [Google Scholar]
  19. Sun X. W., Ellerbrock T. V., Lungu O., Chiasson M. A., Bush T. J., Wright T. C., Jr Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1995 May;85(5 Pt 1):680–686. doi: 10.1016/0029-7844(95)00025-m. [DOI] [PubMed] [Google Scholar]
  20. Sun X. W., Kuhn L., Ellerbrock T. V., Chiasson M. A., Bush T. J., Wright T. C., Jr Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997 Nov 6;337(19):1343–1349. doi: 10.1056/NEJM199711063371903. [DOI] [PubMed] [Google Scholar]
  21. Vandenvelde C., Van Beers D. Risk factors inducing the persistence of high-risk genital papillomaviruses in the normal cervix. J Med Virol. 1992 Nov;38(3):226–232. doi: 10.1002/jmv.1890380313. [DOI] [PubMed] [Google Scholar]
  22. Vermund S. H., Kelley K. F., Klein R. S., Feingold A. R., Schreiber K., Munk G., Burk R. D. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol. 1991 Aug;165(2):392–400. doi: 10.1016/0002-9378(91)90101-v. [DOI] [PubMed] [Google Scholar]
  23. Villa L. L., Franco E. L. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst. 1989 Mar 1;81(5):332–340. doi: 10.1093/jnci/81.5.332. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES